References
Abou-Donia, MB, Wilmarth, KR, Jensen, KF, Oehme, FW, Kurt, TL. (1996). Neurotoxicity resulting from co-exposure to pyridostigmine bromide, DEET, and permethrin. Journal of Toxicology and Environmental Health 48: 101–122.
Ahuja, EM. (1994). VA Medical market share among service-connected veterans. Statistical Brief SB 008-94-1 Washington, D.C.: National Center for Veterans Analysis and Statistics, Assistant Secretary for Policy and Planning, U.S. Department of Veterans Affairs.
Army Regulation 40-562. (November 1, 1995). By order of the Secretaries of the Air Force, Army, Navy, and Transportation.
Arrowsmith-Lowe JB, Anello C. (1994). A view from a regulatory agency. In Strom, BL (ed.) Pharmacoepidemiology 2nd Edition New York: Wiley.
Berenbaum, MC. (1981). Criteria for analyzing interactions between biologically active agents Advances in Cancer Research 35: 269–335.
Berenbaum, MC. (1985). The expected effect of a combination of agents: The general solution Journal of Theoretical Biology 114: 413–431.
Chemical Casualty Care Office, U.S. Army Medical Research Institute of Chemical Defense. (1995). Medical management of chemical casualties (2nd edition). Aberdeen, MD: Medical Research Institute of Chemical Defense.
El-Masri, HA, Thomas, RS, Mumtaz, MM, Andersen, ME, Yang, RSH (1996). A biologically based mathematical model of the effects of partial hepatectomy on cell cycle kinetics. The Toxicologist 30: 131. (Abstract.)
Farrington, CP, Nash, J, Miller, E. (1996). Case series analysis of adverse reactions to vaccines: a comparative evaluation. American Journal of Epidemiology 143: 1165-1173.
Finney, DJ. (1964). Statistical Methods in Biological Assay, 2nd edition London: Charles Griffin.
Gennings, C, Carter, WH, Jr. (1996). Utilizing concentration-response data from individual components to detect statistically significant departures from additivity in chemical mixtures. Biometrics 51: 264–1277.
Gilman, AG, et al. (1990) Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th edition. New York: Pergamon.
Gizurarson, S. (1996) Optimal delivery of vaccines. Clinical pharmacokinetic considerations Clinical Pharmacokinetics 30: 1–15.
Grabenstein, JD. (1990). Drug interactions involving immunologic agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions Drug Intelligence and Clinical Pharmacy. The Annals of Pharmacotherapy 24: 67–81.
Grabenstein, JD, Schroeder, DL, Bjornson, DC, Hartzewa, AG. (1992). Pharmacoepidemiology and military medical automation: Opportunity for excellence. Military Medicine 57: 302–307.
Greenland, S. (1993). Basic problems in interaction assessment. Environmental Health Perspectives Supplements 101 (Suppl 4): 59-66.
Gutthann, SP, Garcia-Rodriquez, LA. (1993). The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs Epidemiology 4: 496–501.
Hansten, PD, Horn, JH. (1993) Drug Interactions. Philadelphia Lea & Febiger.
Jankel, CA, Speedie, SM. (1990.) Detecting drug interactions: A review of the literature Drug Intelligence and Clinical Pharmacy 24(1): 982–989.
Jankel, CA, Fitterman, LK. (1993) Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Safety 9: 51–59.
Kelly, C, Rice, J. (1990) Monotone smoothing with application to dose-response curves and the assessment of synergism. Biometrics 46: 1071–1085.
Kessler, DA. (1993) Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems Journal of the American Medical Association 269: 2765–2768.
Kramer, P, McClain, CJ. (1981) Depression of aminopyrine metabolism by influenza vaccine. New England Journal of Medicine 305: 1262–1264.
Krishnan, K, Brodeur, J. (1991) Toxicologic consequences of combined exposure to environmental pollutants. Archives of Complex Environmental Studies 3(3): 1–106.
Levy, RH, Bajpai, M. (1995). Phenytoin. Interactions with other drugs: Mechanistic aspects. In Levy, RH Mattison, RH and Meldrug, BS (eds.). Anti-epileptic Drugs, 4th Edition. New York: Raven.
Liang, KY, Zeger, SL. (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42(1): 121–130.
Machado, SG, Robinson, GA. (1994). A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Statistics in Medicine 13: 2289-2309.
Mauderly, JL. (1993) Toxicological approaches to complex mixtures. Environmental Health Perspectives Supplements 101 (Suppl 4): 155-165.
McClain, CJ, Kromhout, JP, Peterson, FJ, Holtzman, JL. (1980). Potentiation of acetaminophen hepatotoxicity by alcohol. Journal of the American Medical Association 244: 251-253.
Narotsky, MG, Weller, EA, Chinchilli, VM, Kavlock, RJ. (1995). Nonadditive developmental toxicity in mixtures of trichloroethylene, di(2-ethylhexyl) phthalate, and heptachlor in a 5 × 5 × 5 design. Fundamental and Applied Toxicology 27: 203–216.
National Research Council. (1988). Complex Mixtures. Washington, D.C.: National Academy Press.
National Research Council. (1994a). Health Effects of Permethrin-Impregnated Army Battle-Dress Uniforms. Committee on Toxicology. Washington, D.C.: National Academy Press.
National Research Council. (1994b). Aggregation. In Science and Judgment in Risk Assessment. Washington, D.C.: National Academy Press.
Page, WF, Braun, MM, Caporaso, NE. (1995). Ascertainment of mortality in the U.S. veteran population: World War II veteran twins. Military Medicine 160: 351–355.
Page, WF, Mahan, CM, Kang, HK. (1996). Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Annals of Epidemiology 6: 102–109.
Piesner, A, Arlien-Soborg, P, Herning, M. (1996). Neurological complications and Japanese encephalitis vaccination. Lancet 348: 202–203.
Prentice, RL, Smythe, RT, Krewski, D, Mason, M. (1992). On the use of historical control data to estimate dose response trends in quantal bioassay. Biometrics 48: 459–478.
Strom, BL (ed). (1994). Pharmacoepidemiology, 2nd edition. New York: Wiley.
Tarto, DS (ed.). (1995). Drug Interaction Facts. St. Louis: Lippincott.
Thomas, RS, Chubb, LS, Constan, AA, Benjamin, SA, El-Masri, HA, and Yang, RSH. (1996). A comparison of quantitative, immunohistochemical markers for cell-cycle specific changes in F344 rats. The Toxicologist 30: 130. (Abstract.)
Thompson, D, Oster, G. (1996). Use of terfenadine and contraindicated drugs. Journal of the American Medical Association 275: 1339-1341.
Udall JA. (1974). Warfarin-choral hydrate interaction. Pharmacological activity and clinical significance. Annals of Internal Medicine 81: 341-344.
U.S. Department of Defense (1995). Immunizations and Chemoprophylaxis. Army Regulation 40-562. Bolling AFB, Washington, D.C.: U.S. Department of Defense.
U.S. Environmental Protection Agency (1988). Technical Support Document on Risk Assessment of Chemical Mixtures. EPA-600/8-90/064. Washington, D.C.: U.S. Environmental Protection Agency.
U.S. Office of Science and Technology Policy. (1985). Chemical carcinogens: A review of the science and its associated principles. Federal Register 50: 10372–10418.
